Skip to main content

Advertisement

SpringerLink
Log in

Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren’s syndrome

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The purpose of this study was to evaluate the levels of sRAGE in primary Sjögren’s syndrome (SS), and to assess whether there is an association between sRAGE levels and disease characteristics. Thirteen patients were randomly selected from three subgroups: primary SS, (n = 6), secondary Sjögren’s, (n = 4), and ANA(+) but lacking criteria for further disease classification (n = 3). Levels of serum sRAGE were measured in triplicate using an enzyme-linked immunosorbent assay kit. Mean sRAGE levels were significantly lower in the primary Sjögren’s group. Logistic regression analysis indicated that plasma sRAGE level was a significant predictor of diagnostic status. Analyses using routine serological tests for diagnosing autoimmune disorders failed to reach statistical significance. This preliminary study supports the hypothesis that the RAGE system might participate in the disease pathway of primary SS, and that sRAGE may be a potential biomarker to aid in the diagnosis of primary SS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fox PC, Speight PM (1996) Current concepts of autoimmne exocrinopathy: immunologic mechanisms in the salivary pathology of Sjogren’s syndrome. Crit Rev Oral Biol Med 7:144–158

    PubMed  CAS  Google Scholar 

  2. Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, Jonsson R (2003) Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren’s syndrome. Arthritis Rheum 48:3187–3201

    Article  PubMed  CAS  Google Scholar 

  3. Ohlsson M, Jonsson R, Brokstad K (2002) Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigen during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren’s syndrome. Scand J Immunol 56(5):456–469

    Article  PubMed  CAS  Google Scholar 

  4. Gordon TP, Bolstad AI, Rischmueller M, Jonsson R, Waterman SA (2001) Autoantibodies in primary Sjögren’s syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity 34:123–132

    Article  PubMed  CAS  Google Scholar 

  5. Beroukass D, Goodfellow R, Hiscock J, Jonsson R, Gordon TP, Waterman SA (2002) Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjogren’s syndrome. Lab Invest 82:203–210

    Google Scholar 

  6. Gao J, Cha S, Jonsson R, Opalko J, Peck AB (2004) Detection of anti-type 3 muscarinic acteylcholine receptor autoantibodies in the sera of Sjögren’s syndrome patients by use of a transfected cell line assay. Arthritis Rheum 50:2615–2621

    Article  PubMed  CAS  Google Scholar 

  7. Li J, Ha YM, Ku NY, Choi SY, Lee SJ, Oh SB, Kim JS, Lee JH, Lee EB, Song YW, Park K (2004) Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren’s syndrome. Lab Invest 84(11):1430–1438

    Article  PubMed  CAS  Google Scholar 

  8. Beroukas D, Goodfellow R, Hiscock J, Jonsson R, Gordon TP, Waterman SA (2002) Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjögren’s syndrome. Lab Invest 82:203–210

    PubMed  CAS  Google Scholar 

  9. Bacman S, Sterin-Borda L, Camusso JJ, Arana R, Hubscher O, Borda E (1996) Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren’s syndrome. Clin Exp Immunol 104:454–459

    Article  PubMed  CAS  Google Scholar 

  10. Humphreys-Beher MG, Brayer J, Yamachika S, Peck AB, Jonsson R (1999) An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand J Immunol 49:7–10

    Article  PubMed  CAS  Google Scholar 

  11. Brownlee M (1995) Advanced glycosylation in diabetes and aging. Annu Rev Med 46:223–234

    Article  PubMed  CAS  Google Scholar 

  12. Schmidt AM, Yan SD, Stern DJM (1995) The dark side of glucose. Nat Med 1:1002–1004

    Article  PubMed  CAS  Google Scholar 

  13. Jerums G, Panagiotopoulos S, Forbes J, Osicka T, Cooper M (2003) Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Arch Biochem Biophys 419(1):55–62

    Article  PubMed  CAS  Google Scholar 

  14. Miyata T, Hori O, Zhang J, Yan SD, Ferran L, Iida Y, Schmidt AM (1996) RAGE mediates the interaction of AGE-beta-2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 98(5):1088–1094

    Article  PubMed  CAS  Google Scholar 

  15. Turk Z, Sesto M, Skodlar J, Ferencak G, Pokupec R, Turk N, Stavljenic-Rukavina A (2003) Products of advanced glycation in patients with type 2 diabetes and vascular disease. Ann Clin Biochem 40(Pt 5):552–559

    Article  PubMed  CAS  Google Scholar 

  16. Schmidt AM, Yan SD, Yan SF, Stern DM (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 1498:99–111

    Article  PubMed  CAS  Google Scholar 

  17. Schmidt AM, Yan SD, Yan SF, Stern DM (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory response. J Clin Invest 108:949–955

    PubMed  CAS  Google Scholar 

  18. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern D, Nawroth PP (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83:876–866

    Article  PubMed  CAS  Google Scholar 

  19. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A et al (1999) RAGE mediates a novel proinflammatory axis: the cell surface receptor for S100/calgranulin polypeptides. Cell 97:889–901

    Article  PubMed  CAS  Google Scholar 

  20. Chen Y, Yan SS, Colgan J, Zhang HP, Luban J, Schimdt AM, Stern D, Herold KC (2004) Blockage of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J Immunol 173(2):1399–1405

    PubMed  CAS  Google Scholar 

  21. Drinda S, Franke S, Ruster M, Petrow P, Pullig O, Stein G, Hein G (2005) Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis. Rheumatol Int 25(6):411–413

    Article  PubMed  CAS  Google Scholar 

  22. Katz J, Stavropoulos F, Bhattacharyya I, Stewart C, Perez FM, Caudle RM (2004) Receptor of advanced glycation end product (RAGE) expression in the minor salivary glands of patients with Sjogren’s syndrome: a preliminary study. Scan J Rheumatol 33(3):174–178

    Article  CAS  Google Scholar 

  23. Pillerits R, Bokarewa M, Dahlberg L, Tarkowski A (2005) Decreased levels of soluble receptor for advanced glycation endproducts in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 7(4):R817–R824

    Article  CAS  Google Scholar 

  24. Stern D, Yan SD, Yan SF, Schmidt AM (2002) Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 54:1615–1625

    Article  PubMed  CAS  Google Scholar 

  25. Malherbe P, Richards JG, Gaillard H, Thompson A, Diener C, Schuler A, Huber G (1999) cDNA cloning of a novel secreted isoform of the human receptor for advanced glycation end products and characterization of cells co-expressing cell-surface scavenger receptors and Swedish mutant amyloid precursor protein. Brain Res Mol Brain Res 71:159–170

    Article  PubMed  CAS  Google Scholar 

  26. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S et al (2003) Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370:1097–1109

    Article  PubMed  CAS  Google Scholar 

  27. Park IH, Yeon SI, Youn JH, Choi JE, Sasaki N, Choi IH, Shin JS (2004) Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol Immunol 40:1203–1211

    Article  PubMed  CAS  Google Scholar 

  28. Falcone C, Emanuele D, D’Angelo A, Buzzi MP, Belvito C, Cuccia M, Geroldi D (2005) Plasma levels of soluble receptor for advanced glycation endproducts and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol 25:1032–1037

    Article  PubMed  CAS  Google Scholar 

  29. Geroldi D, Falcone C, Emanuele D (2006) Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target. Curr Med Chem 13(17):1971–1978

    Article  PubMed  CAS  Google Scholar 

  30. Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, Lalla E, Chitnis S, Monteiro J, Stickland MH et al (2002) RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 3:123–135

    Article  PubMed  CAS  Google Scholar 

  31. Moser B, Hudson BI Schmidt AM (2005) Soluble RAGE: a hot new biomarker for the hot joint? Arthritis Res Ther 7(4):142–144

    Article  PubMed  CAS  Google Scholar 

  32. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  PubMed  CAS  Google Scholar 

  33. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic, Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590

    Article  Google Scholar 

  34. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American–European Consensus Group. Ann Rheum Dis 61:554–558

    Article  PubMed  CAS  Google Scholar 

  35. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C et al (2000) Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastases. Nature 405:354–360

    Article  PubMed  CAS  Google Scholar 

  36. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, Nagashima M, Morser J, Arnold B, Preissner KT, Nawroth PP (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198:1507–1515

    Article  PubMed  CAS  Google Scholar 

  37. Hudson BI, Schmidt AM (2004) RAGE: a novel target for drug intervention in diabetic vascular disease. Pharm Res 21(7):1079–1086

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Orphaned Autoimmune Disorders, Department of Oral and Maxillofacial Surgery and Diagnostic Sciences (OMSDS), University of Florida College of Dentistry (UFCD), Box 100414 JHMHC, Gainesville, FL, 32610, USA

    Carol Stewart, Seunghee Cha, Robert M. Caudle, Kathleen Berg & Joseph Katz

Authors
  1. Carol Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seunghee Cha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert M. Caudle
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kathleen Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joseph Katz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carol Stewart.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stewart, C., Cha, S., Caudle, R.M. et al. Decreased levels of soluble receptor for advanced glycation end products in patients with primary Sjögren’s syndrome. Rheumatol Int 28, 771–776 (2008). https://doi.org/10.1007/s00296-008-0529-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-008-0529-4

Keywords

Search

Navigation